Esperion Therapeutics Inc. (NASDAQ:ESPR) Is Currently -44.07% Below Its 52-Week High, But Downside Potential Could Surprise You.
In last trading session, Esperion Therapeutics Inc. (NASDAQ:ESPR) saw 3.88 million shares changing hands with its beta currently measuring 1.02. Company’s recent per share price